Form 4 for APYX Apyx Medical Corp
Accepted 2022-03-22 00:00:00 ET · period of report 2022-03-21 · accession 0000719135-22-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-22 | 2022-03-21 | APYX | Swandal Craig A. | Dir | M - OptEx | $4.98 | +17.0K | 17.0K | New | +$84.7K |
| D | 2022-03-22 | 2022-03-21 | APYX | Swandal Craig A. | Dir | M - OptEx | $0.00 | -17.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-21 | M | A | 17,000 | $4.98 | 17,000 | D | — | — | |
| 2 | Derivative | Stock Option (Option to Buy) | 2022-03-21 | M | D | 17,000 | $0.00 | 0 | D | $4.98 · 2021-08-06 to 2030-08-06 | 17,000 Common Stock |